Fundraising Fox
Iter Investments
Venture capitalSouth Florida · Seed–Series B · 14 people tracked
Find your way into Iter Investments
Sign up to see every warm intro you have to Iter Investments
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Iter Investments team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Iter Investments targets the alternative therapeutics industry with a focus on breakthrough companies advancing mental and behavioral health innovations. The firm brings together a multidisciplinary team of investors, scientists, physicians, and technologists to support entrepreneurs building companies with the potential to revolutionize mental health and well-being globally.
Source: firm website, verified Aug 5, 2026.
Team · 14 people
from the firm's website & curated & public directories
What they invest in
from 15 of 26 portfolio companiesMental Health ×12Biotech ×8Digital Health ×8Healthtech ×6Wellness & Fitness ×5AI & Machine Learning ×3Medical Devices ×3Deep Tech ×2
HQs:United States×6Canada×3
Who they back
founder profiles across 9 portfolio companiesFounding team size:solo founder×12 founders×53 founders×24+ founders×1
Where their founders studiedfrom 10 founders with education data
University of Oxford ×2
Where their founders worked beforefrom 12 founders with career history
AltMed Enterprises ×2Entheos Labs ×2Massachusetts General Hospital ×2McKinsey & Company ×2University of South Florida ×2
Investments · 26 tracked
founders shown can be your intro pathBy year:2026 · 12021 · 34 dated
Apex Labs is a biotechnology and emerging therapeutics company developing clinical solutions, likely focused on psychedelic-assisted therapies and drug development.
BiotechDigital HealthMedical DevicesMental Health
Tyler Powell(Chief Executive Officer, co-Founder & Director)inArron Victory(Chief Strategy Officer, co-Founder & Director)inDr. Peter Tomlinson(Chief Technical Officer, co-Founder & Director)inDr. Orion Lekos(SVP Research & co-Founder)
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao
Co-investorsBailey Venture PartnersFJ LabsLeafy TunnelMaiora Rebel VenturesNoeticPalo Santo VC+4 more
Beckley Retreats operates research-informed, legal psilocybin retreat programs, combining pre-retreat preparation, guided psilocybin sessions, and post-retreat integration for individuals seeking personal growth and greater connection.
Mental HealthTravel & HospitalityWellness & FitnessFrederick, US
Neil Markey(Executive Officer, Director)inAZA Allsop(Head of Research)inRock Feilding-Mellen(Director)
Fluence provides training and professional development in psychedelic therapy and integration for clinicians and researchers.
Digital HealthEdTechHealthtechMental Health
Co-investorsJLS
Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.
BiotechDigital HealthMental Health
Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in
Co-investorsBeni Venture CapitalEvolution VC PartnersLongeVCManta Ray VenturesPsyMed VenturesUnruly Capital+2 more
Muse is a brain-sensing wearable platform that combines EEG and fNIRS technology to help users improve sleep, manage stress, and enhance cognitive performance through real-time neurofeedback.
AI & Machine LearningConsumerHardwareHealthtechWellness & FitnessToronto, CA
Ariel Garten(Co-founder and Chief Evangelism Officer)inChris Aimone(Co-founder and Chief Innovation Officer)inTrevor Coleman(Executive Officer, Director)inDerek Luke(Executive Officer)Jean-Michel Fournier(Chief Executive Officer)in
BoardJason Wong(Director)
Co-investorsFf Venture CapitalInnovative Solutions CanadaNew Ground VenturesOMERS Ventures
Nucleus is a venture studio that launches, acquires, and partners with brands and technologies focused on mental wellness and the psychedelic medicine industry.
Digital HealthMental HealthWellness & Fitness
Co-investorsDelta-v Capital
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US
Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)inScott Rairigh(EVP, Corporate Development)inMagali Haas(Chief Medical Officer)in
Co-investorsBonaventure Equity, LLCMystic Ventures
Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use.
BiotechDeep TechHealthtechMedical DevicesMental Health
Danny Motyka(Co-Founder & CEO)inPeter van der Heyden(Co-Founder & Director)in
Co-investorsNoeticEight Capital
PsyTechGlobal provides educational content and business insights on the psychedelics industry, including research tracking and market analysis.
Media & EntertainmentWellness & FitnessPortland, US
Quantified Citizen operates a platform that enables health research studies to be conducted by making the research creation process accessible and globally distributed.
Digital HealthHealthtechMental HealthSaaS
Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases.
BiotechDigital HealthHealthtechMental HealthNew York, US
John Andreadis(Executive Officer, Director)Jan-Anders Karlsson(Executive Officer, Director)Philip Taub(Director)Tim Schlidt(Director)
Co-investorsPsyMed Ventures
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersMission BiocapitalPalo Santo VCRoute 66 VenturesService Provider Capital+3 more
TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.
AgTechMental HealthWellness & FitnessVenice, US
Nanea Reeves(Founder)inZachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)
BoardTim Chang(Director)
Co-investorsBeni Venture CapitalBitkraft Esports VenturesGrit Capital PartnersHartmann CapitalMayfield FundPresence Capital+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
aNUmaAwakn Life SciencesClairvoyantClairvoyantrxFluenceFreedom BioMAPSMuseNucleus HoldingPsyTechWesana
Exits · 1
1 acquisitionsAwkn Life Sciences Incacq. by Solvonis Therapeutics
Portfolio news
latest coverage across their companies
Frequently asked questions
- How many investments has Iter Investments made?
- Iter Investments has 26 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Iter Investments invest at?
- Iter Investments invests at the Seed, Series A, Series B stages.
- What sectors does Iter Investments focus on?
- Iter Investments focuses on Healthtech, Mental Health, Wellness & Fitness.
- Where is Iter Investments located?
- Iter Investments is headquartered in South Florida, US.
- Who does Iter Investments co-invest with?
- Iter Investments most often shares deals with PsyMed Ventures, Beni Venture Capital, Bonaventure Equity, LLC, among 33 tracked co-investors.
Media · Podcasts & interviews
featuring the teamr/shroomstocks - Host Dustin Robinson of Iter Investments is joined in conversation by the Founder and CEO of Adamo Bioscience, Dr. Molly Maloof. While in the hot seat, Dr. Molly answers tough questions that every investor should know about Adamo Bioscience. Airs live June/23/2020 (Today) @ 4pm est.
Dustin Robinson · reddit.com
TIME TO INVEST IN Psychedelic Stocks | Iter Investments Founder Dustin Robinson Explains Why!
InvestorPlace · Dustin Robinson
Images
Similar investors
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
Figure 8 Investments (Figure Eight Investments) is an impact-oriented family office founded by an educator and a serial entrepreneur, investing in companies advancing inclusive education, healthcare, and climate solutions.
2050 is a mission-driven venture capital firm that invests in companies aligning their economic development with the interests of people, society and the planet. Its fund is structured to remain open for 99 years and is governed by a Perpetual Purpose Trust.
naturalX Health Ventures is a €100 million venture capital fund backed by Schwabe Group, a global leader in plant-based pharmaceuticals, investing in consumer health companies at the intersection of wellness and medicine.